Effect of Omega-3 supplementation in patients with multiple sclerosis
Phase 3
Recruiting
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20240702062304N1
- Lead Sponsor
- Abadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with MS (diagnosis of MS based on McDonald's criteria)
Age 18 to 85 years
All types of MS (relapsing-remitting and progressive types)
Treated with MS course-modifying drugs at a fixed dose for 6 months before study enrollment
Exclusion Criteria
Participants in other trials except the present clinical trial
Recurrence or treatment with corticosteroids in the last month
Simultaneous treatment with antibiotics and antihypertensive drugs
Other acute or severe diseases except MS
Pregnancy
Current or past history of ventricular arrhythmia
A general health condition that interferes with participation in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method